ESOMEPRAZOLE MAGNESIUMD/R (DirectRX)
Welcome to the PulseAid listing for the ESOMEPRAZOLE MAGNESIUM drug offered from DirectRX. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | DirectRX |
NON-PROPRIETARY NAME: | ESOMEPRAZOLE MAGNESIUM |
SUBSTANCE NAME: | ESOMEPRAZOLE MAGNESIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
ESOMEPRAZOLE MAGNESIUM D/R HUMAN PRESCRIPTION DRUG Details:
Item Description | ESOMEPRAZOLE MAGNESIUM D/R from DirectRX |
LABELER NAME: | DirectRX |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61919-834_267916e4-c6ac-43b5-9d81-be20ff1b15d2 |
PRODUCT NDC: | 61919-834 |
APPLICATION NUMBER: | ANDA078279 |
Other ESOMEPRAZOLE MAGNESIUM Pharmaceutical Manufacturers / Labelers: